Literature DB >> 14696453

Clinical characteristics of patients with cryptogenic liver cirrhosis in Okinawa, Japan.

Hiroshi Sakugawa1, Hiroki Nakasone, Tomofumi Nakayoshi, Yuko Kawakami, Tsuyoshi Yamashiro, Tatsuji Maeshiro, Kasen Kobashigawa, Fukunori Kinjo, Atsushi Saito.   

Abstract

BACKGROUND/AIMS: The aims of the present study were to determine the prevalence of patients with cryptogenic liver cirrhosis, and to clarify the clinical characteristics of these patients, with special focus on obesity and type 2 diabetes mellitus.
METHODOLOGY: For the case-control study, we selected age- and sex-matched control patients with cirrhosis of known etiology.
RESULTS: Of 404 patients with liver cirrhosis, 40 (9.9%) were diagnosed as having cryptogenic cirrhosis. Of these 40 patients, 29 (73%) were female. The mean age was 66.1 +/- 8.9 (range 40-87 years old), and was significantly higher than that of either virus, or alcohol-related liver cirrhosis patients. Both obesity and type 2 diabetes mellitus were more common in patients with cryptogenic cirrhosis (53% and 40%, respectively) compared with the case-controls (20%, 18%, respectively).
CONCLUSIONS: Cryptogenic liver cirrhosis accounted for approximately 10% of liver cirrhosis, and was associated with both obesity and type 2 diabetes mellitus. Nonalcoholic steatohepatitis sequelae may be the most important etiological factor in patients with cryptogenic liver cirrhosis in Okinawa, Japan, where virus-etiology is more predominant in liver cirrhosis compared with Western countries.

Entities:  

Mesh:

Year:  2003        PMID: 14696453

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  7 in total

Review 1.  Cryptogenic cirrhosis: what are we missing?

Authors:  Stephen Caldwell
Journal:  Curr Gastroenterol Rep       Date:  2010-02

Review 2.  Cryptogenic chronic hepatitis and its changing guise in adults.

Authors:  Albert J Czaja
Journal:  Dig Dis Sci       Date:  2011-06-07       Impact factor: 3.199

Review 3.  Clinical features of nonalcoholic steatohepatitis in Japan: Evidence from the literature.

Authors:  Masafumi Ono; Toshiji Saibara
Journal:  J Gastroenterol       Date:  2006-08       Impact factor: 7.527

4.  Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.

Authors:  Hiroshi Sakugawa; Tomofumi Nakayoshi; Kasen Kobashigawa; Tsuyoshi Yamashiro; Tatsuji Maeshiro; Satoru Miyagi; Joji Shiroma; Akiyo Toyama; Tomokuni Nakayoshi; Fukunori Kinjo; Atsushi Saito
Journal:  World J Gastroenterol       Date:  2005-01-14       Impact factor: 5.742

5.  Epidemiology and risk factors of nonalcoholic fatty liver disease (NAFLD).

Authors:  Ajay Duseja; Naga Chalasani
Journal:  Hepatol Int       Date:  2013-11-02       Impact factor: 6.047

6.  Pioglitazone, quercetin and hydroxy citric acid effect on hepatic biomarkers in Non Alcoholic Steatohepatitis.

Authors:  Krishna Mohan Surapaneni; Mallika Jainu
Journal:  Pharmacognosy Res       Date:  2014-04

7.  Explant liver evaluation decodes the mystery of cryptogenic cirrhosis!

Authors:  Mayank Jain; Jayanthi Venkataraman; Joy Varghese; Mukul Vij; Mettu S Reddy; Mohamed Rela
Journal:  JGH Open       Date:  2019-05-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.